Dermata Therapeutics, Inc. DRMA
0.65 USD -0.06 (-8.99%)
Nov 11, 2026, 11:30 AM EST
0.6503 Day range 0.74
0.603 52-week range 4.66
- YTD
- -71.97%
- 1 year
- -79.74%
News
benzinga.com Dermata Therapeutics Q3 EPS $(0.55), Inline Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(0.55) per share which met the analyst consensus estimate. This is a 66.67 percent increase over losses of $(1.65) per share from the…
benzinga.com Dermata Therapeutics Enrolls First Participant In Its Clinical Trial Evaluating Tome Clearing Treatment For Acne; Expects To Launch This Second Commercial Product In H1 2027 The initiation of this clinical trial marks another milestone in Dermata's strategy by adding a second product to its Tome skincare portfolio, targeting significant opportunities in the consumer…
benzinga.com Why Is Dermata Therapeutics Stock Gaining Thursday? Dermata Therapeutics (DRMA) jumps 34% after positive clinical results for its weekly Bioneedle Tome Foundational Treatment.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Regencell Bioscience (NASDAQ:RGC) stock increased by 30.4% to $10.58 during Thursday's regular session. The company's market cap stands at $4.0 billion. SenesTech (NASDAQ:SNES) stock rose…
benzinga.com Dermata Therapeutics Announces Over 71% Of Patients Had Overall Skin Improvements At Day 29 In Its Cosmetic Clinical Trial Of Tome Foundational Treatment Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, today announced positive topline results from its recently completed cosmetic
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers InnovAge Holding (NASDAQ:INNV) shares increased by 10.8% to $11.65 during Tuesday's after-market session. The company's market cap stands at $1.4 billion. The company's, Q4 earnings came out…- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's pre-market session. The company's market cap stands at $7.2 million. LENSAR (NASDAQ:LNSR) shares…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers BioVie (NASDAQ:BIVI) shares increased by 39.4% to $1.77 during Wednesday's regular session. The market value of their outstanding shares is at $9.5 million. Sionna Therapeutics (NASDAQ:SION)…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Bone Biologics (NASDAQ:BBLG) stock moved upwards by 17.7% to $1.07 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6 million. Definium Therapeutics
benzinga.com Dermata Therapeutics Stock Surges 27% Pre-Market: Why is it Moving? Dermata Therapeutics shares jumped 28.73% pre-market after reporting second-quarter results and preparing for its upcoming skincare product launch.
benzinga.com Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket CRWV shares rose in pre-market trading after reporting better-than-expected Q2 results. BAOS, BOXL, DOGZ, DRMA, ZBAO, HYLN, XHLD, VELO, and HRB also saw gains.- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 44.4% to $1.56 during Tuesday's after-market session. The company's market cap stands at $4.5 million. As per the news, the Q2…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com Dermata Therapeutics Q1 EPS $(0.48) Beats $(0.53) Estimate Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.53) by 9.43 percent. This is a 89.33 percent increase over losses of…
- benzinga.com Dermata Therapeutics Secures Australian Patent Acceptance For Bioneedle System In Dermal Fillers - This would be Dermata's first patent, if issued, covering the use of its Bioneedle Delivery System ("BDS") with dermal fillers -- The Company also has allowed and issued patents in the US,…
benzinga.com Dermata Therapeutics Q4 EPS $(1.52) Beats $(1.54) Estimate Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(1.52) per share which beat the analyst consensus estimate of $(1.54) by 1.3 percent. This is a 83.48 percent increase over losses of…- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com Dermata Shares Rise After USPTO Issues Patent Notice Of Allowance Dermata Therapeutics shares are trading higher Friday after the USPTO issued a notice of allowance for a patent on skin condition treatment.- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Why Planet Labs Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket Planet Labs (PL) stock rose in pre-market trading after better-than-expected Q4 sales and strong FY27 guidance. Top gainers include JDZG, AZTR, YYGH, DRMA, WNW, RPGL, JEM, FDX, and FLY. Top losers…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session 
benzinga.com UPDATE: Dermata Therapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS" - benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Why Comfort Systems Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com The Australian Patent Office Grants Dermata Therapeutics' Patent Application for Its Spongilla Technology Combination as a Method for Treating Acne The Company's innovative acne kit represents a new approach to acne treatment by targeting the underlying acne-causing mechanisms with enhanced precision and effectiveness. Unlike traditional…
benzinga.com Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com Stock Market Today: S&P 500, Dow Jones Futures Trade Mixed Amid Blip In Santa Claus Rally—Boeing, Freeport-McMoRan, Fonar In Focus U.S. stock futures swung between gains and losses on Tuesday after Monday’s declines. Futures of major benchmark indices were mixed. The Santa Claus rally, which began on Dec. 24 last week, seems to…
benzinga.com Why Fonar Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket 
benzinga.com Verastem, TEN Holdings And 3 Stocks To Watch Heading Into Tuesday U.S. stock futures mixed on Tuesday, potential stocks to watch: TEN Holdings up 17%, Fonar up 24%, CapsoVision down 11%.
benzinga.com Why Aptevo Therapeutics Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Friday's Mid-Day Session - benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com Why Is Dermata Therapeutics Stock Surging Wednesday? Dermata Therapeutics rose after announcing a private placement offering of common shares, Series C warrants, and Series D warrants.- benzinga.com Dermata Therapeutics Announces Private Placement Up To $12.4M Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, today announced that it has entered into definitive agreements…
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com Dermata Therapeutics Q3 EPS $(1.65) Misses $(1.59) Estimate Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(1.65) per share which missed the analyst consensus estimate of $(1.59) by 3.77 percent. This is a 91.92 percent increase over losses…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
benzinga.com Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com Dermata Therapeutics Announces Australian Patent Office Accept Patent Application For Spongilla Technology Combination As Method For Treating Acne - This acceptance follow's Dermata's U.S. issued patent covering its Spongilla technology combination as a method to topically treat acne -- Dermata expects to launch a new once-weekly,…